VNDA
Vanda Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$430.90M
P/E Ratio
—
EPS
$-3.74
Beta
0.71
52W High
$9.94
52W Low
$3.81
50-Day MA
$7.66
200-Day MA
$5.88
Dividend Yield
—
Profit Margin
-102.00%
Forward P/E
86.96
PEG Ratio
2.23
About Vanda Pharmaceuticals Inc
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company is headquartered in Washington, the District of Columbia.
Fundamentals
| Revenue (TTM) | $216.10M |
| Gross Profit (TTM) | $203.06M |
| EBITDA | $-143.06M |
| Operating Margin | -70.50% |
| Return on Equity | -50.90% |
| Return on Assets | -16.50% |
| Revenue/Share (TTM) | $3.67 |
| Book Value | $5.54 |
| Price-to-Book | 1.26 |
| Price-to-Sales (TTM) | 1.99 |
| EV/Revenue | 0.752 |
| EV/EBITDA | 0.76 |
| Quarterly Earnings Growth (YoY) | -95.90% |
| Quarterly Revenue Growth (YoY) | 7.60% |
| Shares Outstanding | $59.11M |
| Float | $53.41M |
| % Insiders | 8.36% |
| % Institutions | 72.75% |
Analyst Ratings
Consensus ($15.50 target)
3
Buy1
HoldData last updated: 4/9/2026